A prospective randomized trial of imipenem-cilastatin versus clindamycin/tobramycin in the treatment of intra-abdominal and pelvic infections

Documenti analoghi

• Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections.
  di: Solomkin, J S, et al.
  Pubblicazione: (1990)
• Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections.
  di: Brismar, B, et al.
  Pubblicazione: (1992)
• Prospective, randomized, double-blind comparison of metronidazole and tobramycin with clindamycin and tobramycin in the treatment of intra-abdominal sepsis.
  di: Smith, J A, et al.
  Pubblicazione: (1980)
• Imipenem (N-F-thienamycin) versus netilmicin plus clindamycin. A controlled and randomized comparison in intra-abdominal infections.
  di: Gonzenbach, H R, et al.
  Pubblicazione: (1987)
• Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection
  di: Lucasti, Christopher, et al.
  Pubblicazione: (2016)